The NMDA antagonist budipine can alleviate levodopa-induced motor fluctuations.
Identifieur interne : 007700 ( Main/Merge ); précédent : 007699; suivant : 007701The NMDA antagonist budipine can alleviate levodopa-induced motor fluctuations.
Auteurs : S. Spieker [Allemagne] ; P A Löschmann ; T. KlockgetherSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 1999.
English descriptors
- KwdEn :
- Adult, Aged, Antiparkinson Agents (adverse effects), Dose-Response Relationship, Drug, Dyskinesia, Drug-Induced (diagnosis), Dyskinesia, Drug-Induced (drug therapy), Dyskinesia, Drug-Induced (etiology), Female, Humans, Levodopa (adverse effects), Male, Middle Aged, N-Methylaspartate (antagonists & inhibitors), Parkinson Disease (drug therapy), Pilot Projects, Piperidines (pharmacology), Piperidines (therapeutic use), Severity of Illness Index.
- MESH :
- chemical , adverse effects : Antiparkinson Agents, Levodopa.
- chemical , antagonists & inhibitors : N-Methylaspartate.
- diagnosis : Dyskinesia, Drug-Induced.
- drug therapy : Dyskinesia, Drug-Induced, Parkinson Disease.
- etiology : Dyskinesia, Drug-Induced.
- chemical , pharmacology : Piperidines.
- chemical , therapeutic use : Piperidines.
- Adult, Aged, Dose-Response Relationship, Drug, Female, Humans, Male, Middle Aged, Pilot Projects, Severity of Illness Index.
PubMed: 10348483
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 004190
- to stream PubMed, to step Curation: 004190
- to stream PubMed, to step Checkpoint: 004093
- to stream Ncbi, to step Merge: 000062
- to stream Ncbi, to step Curation: 000062
- to stream Ncbi, to step Checkpoint: 000062
Links to Exploration step
pubmed:10348483Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The NMDA antagonist budipine can alleviate levodopa-induced motor fluctuations.</title>
<author><name sortKey="Spieker, S" sort="Spieker, S" uniqKey="Spieker S" first="S" last="Spieker">S. Spieker</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, University of Tübingen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, University of Tübingen</wicri:regionArea>
<wicri:noRegion>University of Tübingen</wicri:noRegion>
<wicri:noRegion>University of Tübingen</wicri:noRegion>
<wicri:noRegion>University of Tübingen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Loschmann, P A" sort="Loschmann, P A" uniqKey="Loschmann P" first="P A" last="Löschmann">P A Löschmann</name>
</author>
<author><name sortKey="Klockgether, T" sort="Klockgether, T" uniqKey="Klockgether T" first="T" last="Klockgether">T. Klockgether</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1999">1999</date>
<idno type="RBID">pubmed:10348483</idno>
<idno type="pmid">10348483</idno>
<idno type="wicri:Area/PubMed/Corpus">004190</idno>
<idno type="wicri:Area/PubMed/Curation">004190</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004093</idno>
<idno type="wicri:Area/Ncbi/Merge">000062</idno>
<idno type="wicri:Area/Ncbi/Curation">000062</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000062</idno>
<idno type="wicri:doubleKey">0885-3185:1999:Spieker S:the:nmda:antagonist</idno>
<idno type="wicri:Area/Main/Merge">007700</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The NMDA antagonist budipine can alleviate levodopa-induced motor fluctuations.</title>
<author><name sortKey="Spieker, S" sort="Spieker, S" uniqKey="Spieker S" first="S" last="Spieker">S. Spieker</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, University of Tübingen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, University of Tübingen</wicri:regionArea>
<wicri:noRegion>University of Tübingen</wicri:noRegion>
<wicri:noRegion>University of Tübingen</wicri:noRegion>
<wicri:noRegion>University of Tübingen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Loschmann, P A" sort="Loschmann, P A" uniqKey="Loschmann P" first="P A" last="Löschmann">P A Löschmann</name>
</author>
<author><name sortKey="Klockgether, T" sort="Klockgether, T" uniqKey="Klockgether T" first="T" last="Klockgether">T. Klockgether</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1999" type="published">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Dose-Response Relationship, Drug</term>
<term>Dyskinesia, Drug-Induced (diagnosis)</term>
<term>Dyskinesia, Drug-Induced (drug therapy)</term>
<term>Dyskinesia, Drug-Induced (etiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Levodopa (adverse effects)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>N-Methylaspartate (antagonists & inhibitors)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Pilot Projects</term>
<term>Piperidines (pharmacology)</term>
<term>Piperidines (therapeutic use)</term>
<term>Severity of Illness Index</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>N-Methylaspartate</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Piperidines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Piperidines</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Dose-Response Relationship, Drug</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pilot Projects</term>
<term>Severity of Illness Index</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007700 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 007700 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Merge |type= RBID |clé= pubmed:10348483 |texte= The NMDA antagonist budipine can alleviate levodopa-induced motor fluctuations. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:10348483" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |